Keywords: rituxan, plus, chemo, boosts, pfs, ph, iii

Rituxan plus chemo boosts PFS in Ph III CLL trials

Article | 15 December 2008

Print This

US biotechnology firms Genentech and Biogen Idec says that results from two global Phase III studies in chronic lymphocytic leukemia ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in